NCT02410889

Brief Summary

The purpose of this project is to develop the method of combined recording of electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) in order to improve understanding of the relationship between electrical (EEG) and blood flow (fMRI) responses to epileptic discharges as a necessary step towards clinical use. One factor that currently limits the use of EEG-fMRI in patients with epilepsy is that a relatively large proportion of patients do not show any fMRI response despite epileptic activity having been detected on the EEG recorded during scanning. The reasons for this are unclear, which makes it difficult to predict in advance whether useful information will be gained from the scanning session. What is it about some epileptic discharges that results in a detectable change in the fMRI signal, while others which are no less obvious or frequent do not? This question will be addressed by determining the factors that are responsible for the occurrence of robust fMRI signal changes via detailed morphological, topographical and spectral analysis of the EEG signal on an event by event basis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
8.2 years until next milestone

First Submitted

Initial submission to the registry

March 18, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 8, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

October 12, 2016

Status Verified

April 1, 2015

Enrollment Period

9 years

First QC Date

March 18, 2015

Last Update Submit

October 11, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • EEG and fMRI concordance

    Assessment of the concordance between haemodynamic (fMRI) and electrical (EEG) measures of the brain response to epileptic discharges, both in terms of signal properties and localisation

    Day 1

Secondary Outcomes (1)

  • EEG-fMRI clinical concordance

    Day 1

Study Arms (1)

Patients with Epilepsy

A group of patients with a variety of types of epilepsy.

Other: EEG-fMRI scanning

Interventions

Patients undergo EEG-fMRI scanning

Patients with Epilepsy

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with epilepsy with interictal epileptic discharges evident on scalp EEG.

You may qualify if:

  • adults with no contraindications to MRI scanning. Initial screening for MR compatibility will be performed at recruitment.
  • epilepsy with interictal epileptic discharges evident on scalp EEG.
  • rarity or lack of seizures. This is an important point to minimise the risk of the patient having a seizure during scanning.
  • expected rate of interictal epileptic discharges sufficient to allow at least 10 but less than 200 events to be recorded per hour. Both too few and too many events make interpretation of the EEG-fMRI results difficult.
  • willingness to remain in the scanner for a minimum of 40 minutes. This ensures that a reasonable amount of fMRI data is collected. It is important that motivated subjects are recruited, preferably those who have previously undergone MRI scanning and so have some idea of the environment.

You may not qualify if:

  • contraindications to MRI scanning.
  • epilepsy with rare or absent interictal discharges, or frequent seizures.
  • patient is unable to give informed consent or understand the nature of the study.
  • neurological or psychiatric diagnosis other than epilepsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Birmingham

Birmingham, West Midlands, B15 2TT, United Kingdom

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2015

First Posted

April 8, 2015

Study Start

January 1, 2007

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

October 12, 2016

Record last verified: 2015-04

Locations